Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Beta-catenin (CTNNB1) is a dual-function protein crucial for cell-cell adhesion and gene transcription regulation. As a key component of adherens junctions, it bridges cadherins to the actin cytoskeleton. In the canonical Wnt signaling pathway, beta-catenin translocates to the nucleus upon pathway activation and interacts with TCF/LEF transcription factors to regulate the expression of Wnt target genes. Its levels are tightly controlled by the destruction complex, and dysregulation leads to pathological accumulation, notably in various cancers.
Inhibition of beta-catenin degradation; disruption of beta-catenin/TCF/LEF complex; modulation of Wnt signaling pathway
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Beta-catenin.